OptiNose Inc (DELISTED) (OPTN:DL)
9.60
0.00 (0.00%)
USD |
NASDAQ |
May 23, 16:00
OptiNose Total Liabilities (Quarterly) : 176.22M for March 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Akoya Biosciences Inc (DELISTED) | 118.54M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Cassava Sciences, Inc. | 48.16M |
| Aptevo Therapeutics, Inc. | 9.604M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.85M |
| Shareholders Equity (Quarterly) | -61.37M |
| Debt to Equity Ratio | -2.073 |
| Current Ratio | 0.64 |
| Net Debt Paydown Yield | 0.65% |